Literature DB >> 20596659

Fibroblasts associated with cancer cells keep enhanced migration activity after separation from cancer cells: a novel character of tumor educated fibroblasts.

Genichiro Ishii1, Hiroko Hashimoto, Kiyoshi Asada, Takashi Ito, Ayuko Hoshino, Satoshi Fujii, Motohiro Kojima, Takeshi Kuwata, Kenichi Harigaya, Kanji Nagai, Toshikazu Ushijima, Atsushi Ochiai.   

Abstract

It is now clear that the association between cancer cells and recruited fibroblasts (cancer-associated fibroblasts; CAFs) leads to alteration of the biological properties of both types of cells and creates a specific microenvironment. Here we report a novel biological property of CAFs and its cellular mechanism using in vivo and in vitro model. Cultured CAFs derived from human lung cancer tissue displayed significantly higher migration activity in response to PDGF-BB than that of fibroblasts from corresponding non-cancerous tissue (NCAFs). Moreover, KM104GFP (GFP-labeled human fibroblast cell line) co-cultured with human cancer cell line Capan-1 showed significantly higher migration activity than KM104GFP alone. No such phenomenon occurred when KM104GFP and Capan-1 were cultured separately. Even after KM104GFP were sorted from co-cultured Capan-1, KM104GFP retained their enhanced migration activity until passage-5 of culture in the absence of cancer cells. Despite a similar level of phosphorylation of ERK1/2 after exposure to PDGF-BB, the inhibitory effect of MEK inhibitor was significantly higher on migration of KM104GFP that had been sorted from co-cultured Capan-1 than of KM104GFP alone. This higher dependence on ERK1/2 signaling for cell migration was also seen in CAFs obtained from cancer tissue. The results of this study indicate that by association with cancer cells, CAFs can acquire enhanced migration activity which could be kept after separation from cancer cells and suggest the possibility that higher dependence on ERK1/2 signaling for enhanced migration activity would be one of the biological properties of CAFs.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20596659     DOI: 10.3892/ijo_00000680

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  9 in total

1.  Colorectal Cancer-Associated Fibroblasts are Genotypically Distinct.

Authors:  Amy A Mrazek; Joseph R Carmical; Thomas G Wood; Mark R Hellmich; Mahmoud Eltorky; Frederick J Bohanon; Celia Chao
Journal:  Curr Cancer Ther Rev       Date:  2014-01

2.  Cancer cell invasion driven by extracellular matrix remodeling is dependent on the properties of cancer-associated fibroblasts.

Authors:  Shinya Neri; Hiroko Hashimoto; Hiroaki Kii; Hirotada Watanabe; Kenkichi Masutomi; Takeshi Kuwata; Hiroshi Date; Masahiro Tsuboi; Koichi Goto; Atsushi Ochiai; Genichiro Ishii
Journal:  J Cancer Res Clin Oncol       Date:  2015-09-15       Impact factor: 4.553

3.  Significance of cancer-associated fibroblasts in the regulation of gene expression in the leading cells of invasive lung cancer.

Authors:  Jian An; Atsushi Enomoto; Liang Weng; Takuya Kato; Akari Iwakoshi; Kaori Ushida; Keiko Maeda; Maki Ishida-Takagishi; Genichiro Ishii; Shuhong Ming; Tieying Sun; Masahide Takahashi
Journal:  J Cancer Res Clin Oncol       Date:  2012-10-30       Impact factor: 4.553

4.  Podoplanin-expressing cancer-associated fibroblasts inhibit small cell lung cancer growth.

Authors:  Akiko Takahashi; Genichiro Ishii; Shinya Neri; Tatsuya Yoshida; Hiroko Hashimoto; Shigeki Suzuki; Shigeki Umemura; Shingo Matsumoto; Kiyotaka Yoh; Seiji Niho; Koichi Goto; Hironobu Ohmatsu; Kanji Nagai; Akihiko Gemma; Yuichiro Ohe; Atsushi Ochiai
Journal:  Oncotarget       Date:  2015-04-20

5.  CD200-positive cancer associated fibroblasts augment the sensitivity of Epidermal Growth Factor Receptor mutation-positive lung adenocarcinomas to EGFR Tyrosine kinase inhibitors.

Authors:  Masayuki Ishibashi; Shinya Neri; Hiroko Hashimoto; Tomoyuki Miyashita; Tatsuya Yoshida; Yuka Nakamura; Hibiki Udagawa; Keisuke Kirita; Shingo Matsumoto; Shigeki Umemura; Kiyotaka Yoh; Seiji Niho; Masahiro Tsuboi; Kenkichi Masutomi; Koichi Goto; Atsushi Ochiai; Genichiro Ishii
Journal:  Sci Rep       Date:  2017-04-21       Impact factor: 4.379

Review 6.  Signaling pathways in cancer-associated fibroblasts and targeted therapy for cancer.

Authors:  Fanglong Wu; Jin Yang; Junjiang Liu; Ye Wang; Jingtian Mu; Qingxiang Zeng; Shuzhi Deng; Hongmei Zhou
Journal:  Signal Transduct Target Ther       Date:  2021-06-10

7.  Identification of a small-molecule ligand of β-arrestin1 as an inhibitor of stromal fibroblast cell migration accelerated by cancer cells.

Authors:  Kruthi Suvarna; Kaori Honda; Yasumitsu Kondoh; Hiroyuki Osada; Nobumoto Watanabe
Journal:  Cancer Med       Date:  2018-01-29       Impact factor: 4.452

Review 8.  Role of Stromal Paracrine Signals in Proliferative Diseases of the Aging Human Prostate.

Authors:  Kenichiro Ishii; Sanai Takahashi; Yoshiki Sugimura; Masatoshi Watanabe
Journal:  J Clin Med       Date:  2018-04-02       Impact factor: 4.241

9.  Tumor-Stromal Interactions in a Co-Culture Model of Human Pancreatic Adenocarcinoma Cells and Fibroblasts and Their Connection with Tumor Spread.

Authors:  Elena Prieto-García; C Vanesa Díaz-García; Alba Agudo-López; Virginia Pardo-Marqués; Inés García-Consuegra; Sara Asensio-Peña; Marina Alonso-Riaño; Carlos Pérez; Carlos Gómez; Jorge Adeva; Luis Paz-Ares; José A López-Martín; M Teresa Agulló-Ortuño
Journal:  Biomedicines       Date:  2021-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.